{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:12:43Z","timestamp":1789647163550,"version":"4.0.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Egyptian Russian University, Cairo, Egypt"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejmech.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T07:02:19Z","timestamp":1499151739000},"page":"698-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents"],"prefix":"10.1016","volume":"138","author":[{"given":"Mohamed A.","family":"Abdelrahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Elaasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia H.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.07.004_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.08.034","article-title":"Mycobacterium Tuberculosis (MTB) GyrB inhibitors: an attractive approach for developing novel drugs against TB","volume":"124","author":"Chaudhari","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib2","series-title":"Global Tuberculosis Report","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ejmech.2017.07.004_bib3","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.bmc.2015.02.032","article-title":"Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain","volume":"23","author":"Saxena","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","article-title":"Global epidemiology of tuberculosis","volume":"367","author":"Dye","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2017.07.004_bib5","series-title":"Multidrug-resistant Tuberculosis (MDR-TB)","author":"WHO","year":"2013"},{"key":"10.1016\/j.ejmech.2017.07.004_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2015.06.027","article-title":"Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl) phenyl moiety","volume":"101","author":"Bielenica","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nmni.2015.02.007","article-title":"The global threat of antimicrobial resistance: science for intervention","volume":"6","author":"Roca","year":"2015","journal-title":"New Microb. New Infect."},{"key":"10.1016\/j.ejmech.2017.07.004_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ejmech.2016.10.034","article-title":"New family of antimicrobial agents derived from 1,4-naphthoquinone","volume":"124","author":"Janeczko","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2016.07.024","article-title":"Design, synthesis, anticancer, antimicrobial activities and molecular docking studies of theophylline containing acetylenes and theophylline containing 1,2,3-triazoles with variant nucleoside derivatives","volume":"123","author":"Ruddarraju","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cr030101q","article-title":"Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents","volume":"105","author":"Mitscher","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2017.07.004_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2013.10.055","article-title":"Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl) acetyl) piperazin-1-yl) quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents","volume":"71","author":"Suresh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib12","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2174\/092986710791163966","article-title":"Quinoline-based antifungals","volume":"17","author":"Musiol","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2014.07.100","article-title":"Synthesis, biological evaluation and 3D-QSAR study of hydrazide, semicarbazide and thiosemicarbazide derivatives of 4-(adamantan-1-yl) quinoline as anti-tuberculosis agents","volume":"85","author":"Patel","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib14","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2174\/138955709791012247","article-title":"Biological activities of quinoline derivatives","volume":"9","author":"Kumar","year":"2009","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.18433\/J3302N","article-title":"Nonclassical biological activities of quinolone derivatives","volume":"15","author":"Daneshtalab","year":"2011","journal-title":"J.\u00a0Pharm. Pharma. Sci."},{"key":"10.1016\/j.ejmech.2017.07.004_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11164-011-0371-2","article-title":"Cytotoxicity, antioxidant, and antimicrobial activities of novel 2-quinolone derivatives derived from coumarin","volume":"38","author":"Al-Amiery","year":"2012","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2017.07.004_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejmech.2013.10.034","article-title":"Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents","volume":"70","author":"Rachakonda","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2013.05.003","article-title":"Design and synthesis of biquinolone\u2013isoniazid hybrids as a new class of antitubercular and antimicrobial agents","volume":"65","author":"Jardosh","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2016.05.007","article-title":"8-Hydroxyquinolines in medicinal chemistry: a structural perspective","volume":"120","author":"Oliveri","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejmech.2016.07.028","article-title":"Pyrrolidinone and pyrrolidine derivatives: evaluation as inhibitors of InhA and Mycobacterium tuberculosis","volume":"123","author":"Matviiuk","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/cmdc.200600010","article-title":"Design, synthesis, and SAR studies of mefloquine-based ligands as potential antituberculosis agents","volume":"1","author":"Jayaprakash","year":"2006","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","article-title":"Quinoline: a promising antitubercular target","volume":"68","author":"Keri","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2017.07.004_bib23","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bmcl.2009.12.045","article-title":"Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents","volume":"20","author":"Eswaran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.004_bib24","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1016\/j.ejmech.2011.07.033","article-title":"Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents","volume":"46","author":"Thomas","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0014-827X(00)00072-0","article-title":"Building a pharmacophore model for a novel class of antitubercular compounds","volume":"55","author":"Manetti","year":"2000","journal-title":"Il Farm."},{"key":"10.1016\/j.ejmech.2017.07.004_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ejmech.2007.08.003","article-title":"Synthesis and anti-mycobacterial activity of (E)-N\u2032-(monosubstituted-benzylidene) isonicotinohydrazide derivatives","volume":"43","author":"Da Silva Louren\u00e7o","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib27","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.ejmech.2010.04.025","article-title":"Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives","volume":"45","author":"Abdel-Aziz","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib28","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.bmcl.2005.03.065","article-title":"In\u00a0vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes","volume":"15","author":"Maccari","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.004_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molstruc.2005.11.023","article-title":"Experimental and theoretical structure characterization of two isoniazid derivatives: 2,4-Difluoro-N\u2032-isonicotinoylbenzohydrazide and 2,4-dichloro-N\u2032-isonicotinoylbenzohydrazide hydrochloride","volume":"788","author":"Silva","year":"2006","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2017.07.004_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bmcl.2007.11.091","article-title":"Synthesis and antimycobacterial evaluation of new trans-cinnamic acid hydrazide derivatives","volume":"18","author":"Carvalho","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.004_bib31","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1016\/j.bmcl.2005.07.011","article-title":"Synthesis and in\u00a0vitro and in\u00a0vivo antimycobacterial activity of isonicotinoyl hydrazones","volume":"15","author":"Sriram","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.004_bib32","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1016\/j.bmc.2007.05.053","article-title":"Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl) pyridines","volume":"15","author":"Navarrete-V\u00e1zquez","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/157340612800493647","article-title":"Small molecule hydrazide agents to inhibit growth and proliferation of Mycobacterium tuberculosis","volume":"8","author":"Bartzatt","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.01.052","article-title":"Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents","volume":"111","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib35","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0960-894X(03)00393-7","article-title":"N-and C-terminal modifications of negamycin","volume":"13","author":"Raju","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.004_bib36","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.bmc.2007.01.051","article-title":"A\u00a0new modification of anti-tubercular active molecules","volume":"15","author":"Imramovsk\u00fd","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib37","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.1016\/j.bmc.2006.06.049","article-title":"Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2\/4-quinolinecarbaldehyde derivatives","volume":"14","author":"Nayyar","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib38","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.bmc.2005.12.042","article-title":"Synthesis, in\u00a0vitro and in\u00a0vivo antimycobacterial activities of diclofenac acid hydrazones and amides","volume":"14","author":"Sriram","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib39","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bmcl.2005.01.073","article-title":"Synthesis of isonicotinic acid N\u2032-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents","volume":"15","author":"Sinha","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.004_bib40","doi-asserted-by":"crossref","first-page":"13573","DOI":"10.1021\/jp509697n","article-title":"Pyrene schiff base: photophysics, aggregation induced emission, and antimicrobial properties","volume":"118","author":"Kathiravan","year":"2014","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2017.07.004_bib41","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1021\/jm500268j","article-title":"Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor","volume":"57","author":"Liao","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib42","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.3390\/molecules20058800","article-title":"Design, synthesis and antitubercular activity of certain nicotinic acid hydrazides","volume":"20","author":"Eldehna","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.07.004_bib43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ejmech.2004.06.007","article-title":"Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4] thiadiazol-2-yl) methyl-5-oxo-[1,2,4] triazole and 1-(4-phenyl-5-thioxo-[1,2,4] triazol-3-yl) methyl-5-oxo-[1,2,4] triazole derivatives","volume":"39","author":"Demirbas","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib44","article-title":"Synthesis, crystal structure, and biological activity of cis\/trans amide rotomers of (Z)-N\u2032-(2-Oxoindolin-3-ylidene) formohydrazide","volume":"2014","author":"Abdel-Aziz","year":"2014","journal-title":"J.\u00a0Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib45","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1016\/j.bmc.2012.08.047","article-title":"Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice","volume":"20","author":"Dos Santos Filho","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib46","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1002\/ejoc.201402609","article-title":"Mild, stereoselective, and highly efficient synthesis of N-acylhydrazones mediated by CeCl3\u00b7 7H2O in a broad range of solvents","volume":"2014","author":"Dos Santos Filho","year":"2014","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib47","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/poc.610031002","article-title":"Stereochemistry and kinetics of addition of amines to acetylenic ketones","volume":"3","author":"Hamed","year":"1990","journal-title":"J.\u00a0Phys. Org. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.5560\/znb.2013-3102","article-title":"Synthesis of 4-aminocoumarin derivatives with N-substituents containing hydroxy or amino groups","volume":"68","author":"Ivanov","year":"2013","journal-title":"Z.\u00a0Naturforsch. B. J. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2017.07.004_bib50","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.bmcl.2013.12.116","article-title":"Synthesis and antifungal activity of ASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition","volume":"24","author":"Morikawa","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.07.004_bib51","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1086\/599831","article-title":"Resistant Escherichia coli\u2014we are what we eat","volume":"49","author":"Collignon","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2017.07.004_bib52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","article-title":"Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium","volume":"41","author":"Collins","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.07.004_bib53","unstructured":"Discovery Studio 4.0, Accelrys, Co. Ltd, http:\/\/www.accelrys.com\/."},{"key":"10.1016\/j.ejmech.2017.07.004_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3797\/scipharm.1011-02","article-title":"Chemometric QSAR modeling and in silico design of antioxidant NO donor phenols","volume":"79","author":"Mitra","year":"2010","journal-title":"Sci. Pharma"},{"key":"10.1016\/j.ejmech.2017.07.004_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5539\/ijc.v8n1p49","article-title":"Synthesis, biological evaluation and 2D-QSAR studies of novel 6-oxo-pyridine-3-carboxamide derivatives as antimicrobial and antifungal agents","volume":"8","author":"El-Sehrawi","year":"2015","journal-title":"Int. J. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib56","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jcc.540070419","article-title":"Atomic physicochemical parameters for three dimensional structure directed quantitative structure activity relationships I. Partition coefficients as a measure of hydrophobicity","volume":"7","author":"Ghose","year":"1986","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib57","first-page":"1898","article-title":"Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide\/hydrazones: anti\u2013Mycobacterium tuberculosis activity and cytotoxicity","volume":"45","author":"Pavan","year":"2010","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib58","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1016\/j.bmc.2013.09.034","article-title":"Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids","volume":"21","author":"Rodrigues","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib59","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jhet.5570390528","article-title":"Enaminones in heterocyclic synthesis: a new regioselective synthesis of 2,3,6-trisubstituted pyridines, 6-substituted-3-aroylpyridines and 1,3,5-triaroylbenzenes","volume":"39","author":"AlSaleh","year":"2002","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib60","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s12272-012-0904-2","article-title":"Design, synthesis and pharmacophoric model building of novel substituted nicotinic acid hydrazones with potential antiproliferative activity","volume":"35","author":"Abdel-Aziz","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejmech.2017.07.004_bib61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.13005\/ojc\/290216","article-title":"Synthesis of substituted-4-oxo-1, 4-dihydro-3-[1-oxo-2-hydrazino-3-{p-toluenesulfon}] quinoline derivatives and their biological activity against bacterial infections","volume":"29","author":"Srivatava","year":"2013","journal-title":"Orient. J. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1076\/phbi.34.2.87.13201","article-title":"Antimicrobial activity of Annatto (Bixa orellana) extract","volume":"34","author":"Irobi","year":"1996","journal-title":"Int. J. Pharmacogn."},{"key":"10.1016\/j.ejmech.2017.07.004_bib63","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0378-8741(98)00068-3","article-title":"Antimicrobial study of the resinous exudate and of diterpenoids isolated from Eupatorium salvia (Asteraceae)","volume":"62","author":"Urzua","year":"1998","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2017.07.004_bib64","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2017.07.004_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ejmech.2017.07.004_bib66","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3987\/COM-15-13210","article-title":"Synthesis and anticancer activities of thiazoles, 1,3-thiazines, and thiazolidine using chitosan-grafted-poly(vinylpyridine) as basic catalyst","volume":"91","author":"Gomha","year":"2015","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2017.07.004_bib67","first-page":"246","article-title":"Synthesis, QSAR and anticandidal evaluation of 1,2,3-triazoles derived from naturally bioactive scaffolds","volume":"93","author":"Irfan","year":"2015","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2017.07.004_bib68","first-page":"154","article-title":"Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents","volume":"130","author":"Murahari","year":"2017","journal-title":"Eur. J. Org. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417305263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417305263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T13:45:46Z","timestamp":1602423946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417305263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":68,"alternative-id":["S0223523417305263"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.004","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}